28th Apr 2011 07:00
The following amendment has been made to the 'Notification of Results' announcement released on 27 April 2011 at 17:59 under RNS No 5899F.
The date 31 March 2010 was corrected to 31 March 2011.
The full corrected version of the text is shown below.
GW Pharmaceuticals plc
Notification of Results
Porton Down, UK, 28 April 2011: GW Pharmaceuticals plc (AIM: GWP) will be announcing its interim financial results for the six months ended 31 March 2011 on Tuesday 17 May 2011.
Enquiries:
Financial Dynamics | 020 7831 3113 |
Ben Atwell / John Dineen |
Notes to Editors
About GW
GW was founded in 1998 and listed on the AIM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular multiple sclerosis and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. For further information, please visit www.gwpharm.com
Related Shares:
GWP.L